300 related articles for article (PubMed ID: 12730367)
1. Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
Armstrong N; Mayer M; Gouaux E
Proc Natl Acad Sci U S A; 2003 May; 100(10):5736-41. PubMed ID: 12730367
[TBL] [Abstract][Full Text] [Related]
2. A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
Holm MM; Naur P; Vestergaard B; Geballe MT; Gajhede M; Kastrup JS; Traynelis SF; Egebjerg J
J Biol Chem; 2005 Oct; 280(42):35469-76. PubMed ID: 16103115
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
Mayer ML; Ghosal A; Dolman NP; Jane DE
J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
[TBL] [Abstract][Full Text] [Related]
4. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
[TBL] [Abstract][Full Text] [Related]
5. Stargazin interaction with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors is critically dependent on the amino acid at the narrow constriction of the ion channel.
Körber C; Werner M; Hoffmann J; Sager C; Tietze M; Schmid SM; Kott S; Hollmann M
J Biol Chem; 2007 Jun; 282(26):18758-66. PubMed ID: 17483093
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
Armstrong N; Gouaux E
Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
[TBL] [Abstract][Full Text] [Related]
7. Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.
Pentikäinen OT; Settimo L; Keinänen K; Johnson MS
Biochem Pharmacol; 2003 Dec; 66(12):2413-25. PubMed ID: 14637199
[TBL] [Abstract][Full Text] [Related]
8. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate.
Jin R; Horning M; Mayer ML; Gouaux E
Biochemistry; 2002 Dec; 41(52):15635-43. PubMed ID: 12501192
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between agonists and antagonists by the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-selective glutamate receptor. A mutation analysis of the ligand-binding domain of GluR-D subunit.
Lampinen M; Settimo L; Pentikainen OT; Jouppila A; Mottershead DG; Johnson MS; Keinanen K
J Biol Chem; 2002 Nov; 277(44):41940-7. PubMed ID: 12167621
[TBL] [Abstract][Full Text] [Related]
12. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
13. Binding of 5'-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations.
Mendieta J; Gago F; Ramírez G
Biochemistry; 2005 Nov; 44(44):14470-6. PubMed ID: 16262247
[TBL] [Abstract][Full Text] [Related]
14. On the mechanisms of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate.
Fenwick MK; Oswald RE
J Biol Chem; 2010 Apr; 285(16):12334-43. PubMed ID: 20110361
[TBL] [Abstract][Full Text] [Related]
15. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.
Sharp RL; May PC; Mayne NG; Snyder YM; Burnett JP
Eur J Pharmacol; 1994 Jan; 266(1):R1-2. PubMed ID: 7511109
[TBL] [Abstract][Full Text] [Related]
16. Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist.
Vogensen SB; Jensen HS; Stensbøl TB; Frydenvang K; Bang-Andersen B; Johansen TN; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2000 Nov; 12(10):705-13. PubMed ID: 11054828
[TBL] [Abstract][Full Text] [Related]
17. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.
Holley SM; Ahmed AH; Srinivasan J; Murthy SE; Weiland GA; Oswald RE; Nowak LM
Biochemistry; 2012 May; 51(19):4015-27. PubMed ID: 22512472
[TBL] [Abstract][Full Text] [Related]
18. Expression of AMPA/kainate receptors during development of chick embryo retina cells: in vitro versus in vivo studies.
Cristóvão AJ; Oliveira CR; Carvalho CM
Int J Dev Neurosci; 2002 Feb; 20(1):1-9. PubMed ID: 12008069
[TBL] [Abstract][Full Text] [Related]
19. Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
Birdsey-Benson A; Gill A; Henderson LP; Madden DR
J Neurosci; 2010 Jan; 30(4):1463-70. PubMed ID: 20107073
[TBL] [Abstract][Full Text] [Related]
20. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
